Definium Therapeutics Inc. Common Shares vs Sasol Ltd. American Depositary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.01 (market cap $4.59B), while Sasol Ltd. American Depositary Shares trades at $14.87 (market cap $9.69B). The key difference: Sasol Ltd. American Depositary Shares is far larger — about 2.1× Definium Therapeutics Inc. Common Shares's market cap, and Sasol Ltd. American Depositary Shares is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Sasol Ltd. American Depositary Shares for 0 Days on average.
| DFTX | SSL | |
|---|---|---|
Market Cap | $4.59B | $9.69B |
Volume | 2,103,937 | 2,297,057 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $15.14 |
52-Week Low | $10.68 | $5.33 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $13.39B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Sasol Limited is a Johannesburg-headquartered chemicals and energy company that uses its proprietary Fischer-Tropsch technology to convert coal, natural gas, and crude-oil feedstocks into fuels and chemical products such as polymers, solvents, surfactants, and ammonia, with operations across Southern Africa and international chemical manufacturing sites, including in US.
Read more on SSL →